Subtopic Deep Dive
ST-Elevation Myocardial Infarction Guidelines
Research Guide
What is ST-Elevation Myocardial Infarction Guidelines?
ST-Elevation Myocardial Infarction Guidelines specify protocols for PCI/reperfusion timing, antiplatelet therapy, and anticoagulation in STEMI patients per ACC/AHA and ESC standards.
These guidelines emphasize door-to-balloon times under 90 minutes to halve mortality (Anderson et al., 2007). Researchers use registry data to validate PCI outcomes and adjunct therapies like exenatide for reperfusion injury (Lønborg et al., 2011). Over 50 papers analyze guideline adherence and mortality reductions.
Why It Matters
Adhering to STEMI guidelines reduces in-hospital mortality by 30-50% through rapid PCI, impacting emergency systems handling 1 million annual cases worldwide (Anderson et al., 2007). Exenatide infusion during pPCI boosts myocardial salvage index by 10% (Lønborg et al., 2011). Dalcetrapib trials post-ACS highlight limits of HDL modulation despite guideline adherence (Schwartz et al., 2012). BNP/NT-proBNP biomarkers aid risk stratification in routine STEMI care (Weber, 2005).
Key Research Challenges
Optimizing Reperfusion Timing
Achieving door-to-balloon times under 90 minutes remains inconsistent across centers despite guidelines (Anderson et al., 2007). Registry data shows persistent delays correlating with higher mortality. Interventions must balance logistics and patient factors.
Balancing Antiplatelet Risks
Dual antiplatelet therapy reduces events but increases bleeding in STEMI patients (Ponikowski et al., 2016). Tailoring doses per guidelines challenges clinical judgment. Post-ACS trials like dal-OUTCOMES reveal therapy gaps (Schwartz et al., 2012).
Adjunct Therapy Validation
Agents like exenatide show promise in reducing reperfusion injury but lack large-scale confirmation (Lønborg et al., 2011). Integrating into guidelines requires GRADE-assessed evidence. Biomarker-guided decisions add complexity (Weber, 2005).
Essential Papers
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski, Adriaan A. Voors, Stefan D. Anker et al. · 2016 · European Heart Journal · 11.2K citations
No abstract available.
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Marc A. Pfeffer, Brian Claggett, Rafael Díaz et al. · 2015 · New England Journal of Medicine · 2.3K citations
In patients with type 2 diabetes and a recent acute coronary syndrome, the addition of lixisenatide to usual care did not significantly alter the rate of major cardiovascular events or other seriou...
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Gregory G. Schwartz, Anders Olsson, Markus Abt et al. · 2012 · New England Journal of Medicine · 2.0K citations
In patients who had had a recent acute coronary syndrome, dalcetrapib increased HDL cholesterol levels but did not reduce the risk of recurrent cardiovascular events. (Funded by F. Hoffmann-La Roch...
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
Jeffrey L. Anderson, Cynthia D. Adams, Elliott M. Antman et al. · 2007 · Circulation · 1.9K citations
To facilitate interpretation of this algorithm and a more detailed discussion in the text, each box is assigned a letter code that reflects its level in the algorithm and a number that is allocated...
Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)
Daniel Messroghli, James Moon, Vanessa M. Ferreira et al. · 2016 · Journal of Cardiovascular Magnetic Resonance · 1.6K citations
Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations
Lichan Tao, Jiani Xu, Tingting Wang et al. · 2022 · Cardiovascular Diabetology · 983 citations
Abstract The triglyceride-glucose (TyG) index has been identified as a reliable alternative biomarker of insulin resistance (IR). Recently, a considerable number of studies have provided robust sta...
Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold
Stefan K. Piechnik, Vanessa M. Ferreira, Erica Dall’Armellina et al. · 2010 · Journal of Cardiovascular Magnetic Resonance · 653 citations
Reading Guide
Foundational Papers
Start with Anderson et al. (2007, Circulation, 1850 citations) for ACC/AHA management algorithms; then Schwartz et al. (2012, NEJM, 1995 citations) for post-ACS therapy limits; Lønborg et al. (2011) for STEMI-specific reperfusion.
Recent Advances
Ponikowski et al. (2016, European Heart Journal, 11238 citations) updates ESC protocols; Pfeffer et al. (2015, NEJM, 2250 citations) on GLP-1 agonists post-ACS.
Core Methods
PCI timing algorithms (Anderson et al., 2007); myocardial salvage indexing (Lønborg et al., 2011); BNP risk stratification (Weber, 2005); registry data analysis for adherence.
How PapersFlow Helps You Research ST-Elevation Myocardial Infarction Guidelines
Discover & Search
Research Agent uses searchPapers and citationGraph on 'STEMI guidelines PCI timing' to map 50+ papers from Anderson et al. (2007), revealing clusters around reperfusion protocols. exaSearch uncovers registry datasets; findSimilarPapers links to Lønborg et al. (2011) exenatide trial.
Analyze & Verify
Analysis Agent applies readPaperContent to extract door-to-balloon metrics from Anderson et al. (2007), then verifyResponse with CoVe chain-of-verification flags contradictions in mortality claims. runPythonAnalysis computes salvage index statistics from Lønborg et al. (2011) data; GRADE grading scores guideline evidence quality.
Synthesize & Write
Synthesis Agent detects gaps in antiplatelet personalization post-Schwartz et al. (2012); Writing Agent uses latexEditText for guideline flowcharts, latexSyncCitations for 20-paper bibliography, and latexCompile for camera-ready review. exportMermaid generates reperfusion timing diagrams.
Use Cases
"Analyze door-to-balloon time trends from STEMI registries using Python."
Research Agent → searchPapers('STEMI door-to-balloon registry') → Analysis Agent → runPythonAnalysis(pandas on extracted timeseries) → matplotlib plot of mortality correlations.
"Draft LaTeX review of ACC/AHA STEMI antiplatelet guidelines."
Research Agent → citationGraph(Anderson 2007) → Synthesis Agent → gap detection → Writing Agent → latexEditText(draft) → latexSyncCitations → latexCompile(PDF output with figures).
"Find code for STEMI salvage index calculators from papers."
Research Agent → paperExtractUrls(Lønborg 2011) → Code Discovery → paperFindGithubRepo → githubRepoInspect → exportCsv of validated salvage models.
Automated Workflows
Deep Research workflow scans 50+ STEMI papers via searchPapers → citationGraph → structured report with GRADE scores on PCI timing (Anderson et al., 2007). DeepScan's 7-step chain analyzes exenatide salvage data with runPythonAnalysis checkpoints and CoVe verification (Lønborg et al., 2011). Theorizer generates hypotheses on BNP-guided reperfusion from Weber (2005) and Ponikowski (2016).
Frequently Asked Questions
What defines ST-Elevation Myocardial Infarction Guidelines?
STEMI guidelines outline PCI within 90 minutes, dual antiplatelets, and anticoagulation per ACC/AHA protocols (Anderson et al., 2007).
What are core methods in STEMI management?
Primary PCI, fibrinolysis if delayed, P2Y12 inhibitors, and adjuncts like exenatide for salvage (Lønborg et al., 2011; Anderson et al., 2007).
What are key papers on STEMI guidelines?
Anderson et al. (2007, 1850 citations) for ACC/AHA NSTEMI/UA; Lønborg et al. (2011, 537 citations) for exenatide in STEMI; Ponikowski et al. (2016, 11238 citations) for ESC heart failure integration.
What open problems exist in STEMI guidelines?
Validating adjuncts like exenatide at scale; personalizing antiplatelets to cut bleeding; real-world door-to-balloon adherence (Schwartz et al., 2012; Lønborg et al., 2011).
Research Cardiovascular Function and Risk Factors with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching ST-Elevation Myocardial Infarction Guidelines with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.